Fecal Microbiota Transplantation in Kidney Stone Patients
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on
24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.
Phase:
Early Phase 1
Details
Lead Sponsor:
Joshua Stern
Collaborators:
Albert Einstein College of Medicine Litholink Corp University of Minnesota